Unlocking the Therapeutic Potential of Momordica charantia Linn.: From Traditional Use to Modern Drug Discovery
Journal of Natural Remedies · 25.04.2026 · 867-884
DOI: 10.18311/jnr/2026/54587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Remedies, online erschienen am 25.04.2026. Verfasst von Ketaki Shinde und 3 weiteren Autor:innen. Die Arbeit nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Momordica charantia Linn., commonly known as bitter melon or bitter gourd, is an important medicinal plant extensively used in traditional Asian medical systems for the prevention and management of various diseases. This review aims to compile and critically summarise updated information on its phytochemistry, pharmacological activities, toxicological profile, ethnomedicinal uses, and commercial and phytopharmaceutical relevance to support future research and drug development. A comprehensive literature survey was conducted using English-language publications, focusing on pharmacological evaluations, isolation and characterisation of bioactive compounds, toxicological studies, and both traditional and modern applications of M. charantia. Pharmacological investigations have demonstrated a wide range of bioactivities, including hepatoprotective, cardioprotective, and anti-inflammatory effects, as well as other therapeutic effects, from extracts of different plant parts. Numerous bioactive constituents have been identified, such as triterpenes, proteins, steroids, alkaloids, lipids, inorganic components, and phenolic compounds. Several novel molecules, including kuguacin-J, momordicine-I, α-eleostearic acid, momordicoside A, quercetin-3-O-glycoside, cucurbitacin E, and goyaglycoside-G, exhibit significant therapeutic potential. The review also highlights traditional and contemporary uses, phytopharmaceutical formulations, toxicity considerations, and other applications. Despite its long-standing traditional use, many therapeutic claims remain scientifically unvalidated, emphasising the need for further mechanistic and clinical studies to identify active principles and their synergistic effects. Major Findings: M. charantia contains bioactive compounds like triterpenoids, saponins, flavonoids, and peptides with diverse pharmacological effects. Studies show antidiabetic, anticancer, hepatoprotective, cardioprotective, anti-inflammatory, and antioxidant activities, but further mechanistic studies and clinical trials are needed for validation and standardisation.
Zitieren
APA
Shinde, K., Durgawale, T., Tipugade, O., & Shedge, V. (2026). Unlocking the Therapeutic Potential of Momordica charantia Linn.: From Traditional Use to Modern Drug Discovery. Journal of Natural Remedies, 867-884. https://doi.org/10.18311/jnr/2026/54587
Vancouver
Shinde K, Durgawale T, Tipugade O, Shedge V. Unlocking the Therapeutic Potential of Momordica charantia Linn.: From Traditional Use to Modern Drug Discovery. Journal of Natural Remedies. 2026:867-884. doi:10.18311/jnr/2026/54587
BibTeX
@article{Shinde2026,
author = {Shinde, Ketaki and Durgawale, Trupti and Tipugade, Omkar and Shedge, Vaishnavi},
title = {Unlocking the Therapeutic Potential of Momordica charantia Linn.: From Traditional Use to Modern Drug Discovery},
journal = {Journal of Natural Remedies},
year = {2026},
pages = {867--884},
doi = {10.18311/jnr/2026/54587}
}
EUVIMED